Analysis
Probiotic marketing shifts from CFU counts to gut health and consumer experience
Probiotic brands are moving away from 'good bacteria' and CFU counts toward gut ecosystem health and tangible consumer benefits, according to HMT brand strategist Marit Veenstra.
HighRisk Media Newsroom, , 2 min read · Читать по-русски
From 'good bacteria' to the gut barrier
Probiotic marketing is changing: brands are moving away from talk of 'good bacteria' and colony forming units (CFU) toward the idea of a holistic gut ecosystem and measurable benefits. Marit Veenstra, brand strategist at the marketing agency HMT, outlined the shift at the Remedy Nutrafood CDMO conference in Poland on October 22–23. NutraIngredients published the material on November 17, 2026.
Veenstra noted that the category emerged after Japan's Yakult launched its product in 1935. The benefits of 'good bacteria' were always intangible, so repeat purchases relied on brand trust and clear communication. The company remained the sole player for a long time, until Danone brought Activia to the European market roughly 50 years later. Danone focused on digestion and showed the stomach on its packaging to make clear where the effect would be felt.
Today, according to Veenstra, the conversation has shifted to the gut barrier and the microbiome ecosystem. She highlighted Nordic Rebalance, with its fermented oat-based postbiotic ReFerm, which is promoted through gut barrier integrity and related health claims.
Why CFU has stopped working as an argument
As the number of brands grew, many started competing on colony forming units. Veenstra stressed that CFU explains little to the consumer. Research has also shown that many freeze-dried supplements break down in stomach acid before reaching the colon.
In response, brands began promoting delivery technologies: enteric coatings, delayed-release capsules and spore-forming strains. Some companies claimed their bacteria were guaranteed to survive the stomach.
What matters to the consumer
According to Veenstra, more attention now goes to patented, science-backed strains, deep expertise in one health area, and quality backed by transparency. At-home gut tests have become more accessible, but in her view mass-market buyers will not trust such kits.
The key factor, she said, is a tangible effect and enjoyment of the product. If people feel no benefit within a few weeks and do not enjoy taking it, they are unlikely to continue. As a result, most new launches are in functional food and drinks rather than supplements. Veenstra summed up that value is shifting from what is inside the product to what the consumer feels when taking it.
Why it matters
- According to the consultant, consumers stay loyal if they feel a benefit within a few weeks and enjoy taking the product.
- Veenstra believes CFU counts do not explain consumer benefit, so positioning built on them is becoming weaker.
- According to her, most new launches are in functional food and drinks rather than supplements.
Sources
Prepared by AI from the sources above and checked against them (how we work). Spotted a mistake? Write to @highrisk_team.
Get stories like this first
- 📰 Daily briefing — Telegram channel @highrisk_media
- 📡 PSP and payment-method alerts — in our bot
- 🔒 HighRisk Private — closed chat with topics for iGaming, payments, crypto, dating, nutra
- 📄 Post your resume — seen by industry recruiters
probioticsgut healthnutraceuticalsmarketingfunctional foodCDMO
More in Nutra
· 2 min read
SupplySide Global: beverages, jellies, peptides and longevity lead supplement trends per SPINS· 2 min read
Calocurb, a natural appetite-control supplement brand, enters UK market· 2 min read
NMN supplements show no significant cardiorespiratory or cognitive benefit in Japanese trial· 2 min read
Zeus Hygia warns brands: Metaberine GLP-1 study does not mean weight loss